Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
06/2003
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1112354C Stereo specific prepn. of chiral 1-aryl-and 1-heteroaryl-2-substituted ethyl-2-amines
06/24/2003US6583318 Method for synthesis of α-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583180 Glucocorticoid receptor modulators
06/24/2003US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
06/24/2003US6583165 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents
06/24/2003US6583161 Benzenesulfonamides and benzamides as therapeutic agents
06/24/2003US6583157 Quinolinyl and benzothiazolyl modulators
06/19/2003WO2003050073A1 Substituted hydroxyethylamines
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049698A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003US20030114710 Optical information recording medium and novel immonium compound
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114517 Substituted urea neuropeptide Y Y5 receptor antagonists
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114490 New phenylalanine derivatives
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114447 Controlling apoptosis; central nervous system disorders
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469709A1 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003CA2469622A1 Substituted hydroxyethylamines
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1318803A1 Fatty acid synthase inhibitors
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1111521C N-sulphonyl and N-sulphinyl amino acid derivatives as microbicides
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579984 Economical, industrially feasible
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/12/2003WO2003048118A1 5-ht7 receptor antagonists
06/12/2003WO2003048117A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
06/12/2003WO2003048116A2 Esters and amides as ppar-alpha agonists ____________
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2002047679A3 Nonpeptide agonists and antagonists of vasopressin receptors
06/12/2003US20030109752 Purification of racemic mixtures
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109527 Novel hydroxy diphenylurea sulfonamides, compositions and intermediates thereof. The hydroxy
06/12/2003US20030108289 Drop-before-add optical switching and routing system employing grating-based wavelength selective
06/12/2003US20030108275 Optical switch systems using waveguide grating-based wavelength selective switch modules
06/12/2003US20030107798 Wavelength converter using Bragg-grating
06/12/2003CA2469227A1 New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
06/11/2003EP1318143A1 Rare-earth ternary complex
06/11/2003EP1317461A1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
06/11/2003EP1317425A2 Resorcinol derivatives
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317411A1 Derivatives of naphthalene with comt inhibiting activity
06/11/2003EP1317178A1 Fungicidal compositions
06/11/2003EP1105372B1 Methoximinophenylacetic acid amides
06/11/2003EP1066276B1 Process for the synthesis of hiv protease inhibitors
06/10/2003US6576664 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor
06/10/2003US6576632 Biaryl compounds useful as anticancer agents
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003US6576159 Colorants, electroconductive materials; solubility, dissociation
06/10/2003CA2304713C Biphenyl-5-alkanoic acid derivatives and use thereof
06/10/2003CA2232775C Acyl compounds
06/05/2003WO2003045902A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/05/2003WO2003045878A2 2,w-diaminocarboxylic acid compounds
06/05/2003US20030105279 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
06/04/2003EP1316548A1 Acylsulfonamide derivatives
06/04/2003EP1315696A1 Acetylenic sulfonamide derivatives
06/04/2003EP1049666B1 Novel naphthyl-substituted and anilide-substituted sulfonamides
06/04/2003EP1045829B1 Method for producing n-(3-amino-4-fluorophenyl)- sulphonamides, n-(3-amino-4-fluorophenyl) carboxylic acid amides and n-(3-amino-4-fluorophenyl) carbamates
06/04/2003EP1028721B1 N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
06/04/2003EP0980353B1 Cationically polymerizable compositions capable of being coated by electrostatic assistance
06/04/2003EP0973734B1 Crosslinkable bi-sulphonyl derivatives and their uses for preparing ion-exchanging membranes
06/04/2003EP0968180B1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0789578B1 Multicatalytic protease inhibitors
06/04/2003CN1422251A Novel alpha-sulfin-and alpha-sulfonamino acid amide derivatives
06/04/2003CN1422250A Alpha-sulfin-and alpha-sulfonamino acid amide derivatives
06/04/2003CN1422249A Novel alpha-sulfin-and alpha-sulfonamino acid amides
06/04/2003CN1422246A Malonamic acids and derivatives thereof as thyroid receptor ligands
06/04/2003CN1110492C Prodrugs of aspartyl protease inhibitors
06/04/2003CN1110490C Sulfamide-substituted condensed seven-membered ring compound, used as medicine and medical preparation containing the same
06/03/2003US6573387 Synthesis of α,β-substituted amino amides, esters, and acids
06/03/2003US6573288 Compounds are inhibitors of the sodium-dependent bicarbonate/chloride ion exchanger which can be used as medicines for the prophylaxis or treatment of a wide range of diseases, for example the treatment and/or prophylaxis of
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003CA2115432C Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors
05/2003
05/30/2003WO2003043625A1 2-aryl-propionic acids and pharmaceutical compositions containing them
05/30/2003WO2003043624A1 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
05/30/2003WO2003043578A2 Modulators of rho c activity
05/30/2003WO2003018552A3 Aromatic and heteroaromatic acid halides for synthesizing polyamides
05/30/2003WO2002092211A3 Bis (perfluoroalkanesulfonyl) imides and their salts as surfactants/additives for applications having extreme environments and methods therefor
05/30/2003CA2467910A1 Modulators of rho c activity
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/28/2003EP1314723A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 177